HighTower Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $207K | Sell |
1,759
-1,677
| -49% | -$234K | ﹤0.01% | 3451 |
|
|
2025
Q4 | $563K | Buy |
3,436
+529
| +18% | +$82.9K | ﹤0.01% | 2518 |
|
|
2025
Q3 | $389K | Sell |
2,907
-911
| -24% | -$111K | ﹤0.01% | 2820 |
|
|
2025
Q2 | $475K | Sell |
3,818
-2,010
| -34% | -$256K | ﹤0.01% | 2567 |
|
|
2025
Q1 | $742K | Buy |
5,828
+774
| +15% | +$119K | ﹤0.01% | 2175 |
|
|
2024
Q4 | $727K | Sell |
5,054
-180
| -3% | -$25.8K | ﹤0.01% | 2196 |
|
|
2024
Q3 | $773K | Sell |
5,234
-788
| -13% | -$113K | ﹤0.01% | 2089 |
|
|
2024
Q2 | $779K | Sell |
6,022
-18,050
| -75% | -$2.83M | ﹤0.01% | 2005 |
|
|
2024
Q1 | $4.44M | Sell |
24,072
-1,205
| -5% | -$229K | 0.01% | 1021 |
|
|
2023
Q4 | $4.57M | Buy |
25,277
+425
| +2% | +$66.2K | 0.01% | 1014 |
|
|
2023
Q3 | $3.95M | Buy |
24,852
+140
| +0.6% | +$22.9K | 0.01% | 1031 |
|
|
2023
Q2 | $3.5M | Buy |
24,712
+7,167
| +41% | +$1.15M | 0.01% | 1061 |
|
|
2023
Q1 | $2.96M | Sell |
17,545
-762
| -4% | -$136K | 0.01% | 1088 |
|
|
2022
Q4 | $3.12M | Buy |
18,307
+595
| +3% | +$108K | 0.01% | 1050 |
|
|
2022
Q3 | $3.32M | Buy |
17,712
+210
| +1% | +$44.3K | 0.01% | 979 |
|
|
2022
Q2 | $2.84M | Sell |
17,502
-150
| -0.8% | -$23.7K | 0.01% | 1066 |
|
|
2022
Q1 | $3.33M | Buy |
17,652
+197
| +1% | +$37.4K | 0.01% | 1093 |
|
|
2021
Q4 | $4.63M | Sell |
17,455
-375
| -2% | -$101K | 0.01% | 937 |
|
|
2021
Q3 | $5.15M | Buy |
17,830
+1,116
| +7% | +$286K | 0.01% | 807 |
|
|
2021
Q2 | $3.33M | Sell |
16,714
-59
| -0.4% | -$11.4K | 0.01% | 963 |
|
|
2021
Q1 | $3.26M | Sell |
16,773
-664
| -4% | -$136K | 0.01% | 893 |
|
|
2020
Q4 | $3.34M | Buy |
17,437
+308
| +2% | +$56K | 0.01% | 715 |
|
|
2020
Q3 | $2.53M | Buy |
17,129
+2
| +0% | +$286 | 0.01% | 796 |
|
|
2020
Q2 | $2.12M | Sell |
17,127
-90
| -0.5% | -$10.6K | 0.01% | 792 |
|
|
2020
Q1 | $1.66M | Sell |
17,217
-1,575
| -8% | -$152K | 0.01% | 811 |
|
|
2019
Q4 | $1.73M | Buy |
18,792
+1,703
| +10% | +$143K | 0.01% | 908 |
|
|
2019
Q3 | $1.31M | Sell |
17,089
-1,100
| -6% | -$96.2K | 0.01% | 1055 |
|
|
2019
Q2 | $1.56M | Sell |
18,189
-44
| -0.2% | -$3K | 0.01% | 1004 |
|
|
2019
Q1 | $1.08M | Sell |
18,233
-23
| -0.1% | -$1.32K | 0.01% | 1105 |
|
|
2018
Q4 | $962K | Sell |
18,256
-448
| -2% | -$26.3K | 0.01% | 1057 |
|
|
2018
Q3 | $1.04M | Buy |
18,704
+77
| +0.4% | +$3.97K | 0.01% | 1107 |
|
|
2018
Q2 | $877K | Hold |
18,627
| – | – | 0.01% | 1182 |
|
|
2018
Q1 | $675K | Buy |
18,627
+300
| +2% | +$10.6K | 0.01% | 1287 |
|
|
2017
Q4 | $665K | Buy |
18,327
+443
| +2% | +$16K | 0.01% | 1315 |
|
|
2017
Q3 | $686K | Buy |
+17,884
| New | +$750K | 0.01% | 1281 |
|
Other funds holding RGEN
UCFA
VCM
VPM
MC
HighTower Advisors's RGEN Position: Q1 2026 in Review
HighTower Advisors reduced its Repligen (RGEN) stake by 49% in Q1 2026, selling an estimated $234K and leaving 1,759 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.
HighTower Advisors first reported a position in RGEN in Q3 2017 and has held it in 35 quarters since. The position peaked at $5.15M in Q3 2021. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- HighTower Advisors held 1,759 shares of Repligen worth $207K as of Q1 2026.
- HighTower Advisors sold 1,677 Repligen shares in Q1 2026, an estimated $234K.
- Repligen made up ﹤0.01% of HighTower Advisors's portfolio in Q1 2026, its #3451 holding.
- HighTower Advisors first reported a position in Repligen in Q3 2017 and has held it in 35 quarters since.
- HighTower Advisors's Repligen position peaked at $5.15M in Q3 2021.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.